PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Sun Pharma’s future brightens considerably with FDA plant upgrade and China drug deal

Sun Pharma has struck a deal with a Chinese company to develop seven more generic drugs on the mainland. (Image by Alexas_Fotos from Pixabay) After five years of...
Continue Reading →
News

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator, with the UK and France close behind

Innovation in drug delivery accelerating according to new Pharmapack Europe research Paris, 19th August 2019: As predicted by the ‘European drug del...
Continue Reading →
News

Nektar battered over manufacturing issues and Bristol-Myers pullback

(Credit: Julphar ) Shares in Nektar Therapeutics plummeted following the company's disclosure that it administered inactive doses of its experimental drug bempeg...
Continue Reading →
News

Amgen resurgent as court victory for top drug eases doubts

(Credit: Amgen Inc. ) Over the past 17 years, Amgen has earned more than $60 billion from sales of its anti-inflammatory drug Enbrel, which it acquired via a 200...
Continue Reading →
News

Embattled Sun Pharma’s Dilip Shanghvi, with Rs 1 salary, ranks among lowest-paid pharma CEOs

Sun Pharma Managing Director Dilip Shanghvi's 2018 pay took a 99% blow in the wake of management misstep allegations. (Pixabay) The helmsman of Indian’s largest ...
Continue Reading →
News

Humira TV ad buys heat up summer airwaves, blasting competition

Humira repeated its top TV spending in pharma, trouncing the rest of the list. Gilead's Truvada came in a distant No. 2, followed by Pfizer and Bristol-Myers Squibb...
Continue Reading →
News

In rebuke of Novartis, FDA making ‘statement for the world’

(Credit: Getty Images ) The Food and Drug Administration sent Novartis an unambiguous signal this week, indicating the drugmaker could face civil or criminal pen...
Continue Reading →
News

Lawmakers up pressure on Novartis in wake of data manipulation

Sen. Chuck Grassley, the Republican chairman of the powerful Senate Finance Committee, is demanding a full accounting from Novartis of its investigation into faul...
Continue Reading →
News

Teva, Endo among generics paying $70M in California pay-for-delay settlement

(Credit: Pixabay; jarmoluk ) Three generics makers will pay California almost $70 million collectively to resolve allegations they engaged in pay-for-delay deals...
Continue Reading →
News

In reversal, Mallinckrodt puts split plans on hold

(Credit: Flickr; Health Gauge ) Generic drugmaker Mallinckrodt will put on hold plans to split the company into two separate businesses, reversing course due to ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026